Showing results (1-10 of 159) with videos related to
Sort By:
Pageof 16
NPJ Vaccines|May 15, 2023
Optimal global spending for group A Streptococcus vaccine research and developmentDaniel Tortorice, Maddalena Ferranna, David E BloomAmerican Journal of Public Health|April 15, 2021
The Societal Value of Vaccination in the Age of COVID-19David E Bloom, Daniel Cadarette, Maddalena FerrannaPlos Medicine|January 11, 2021
Social determinants of mortality from COVID-19: A simulation study using NHANESBenjamin Seligman, Maddalena Ferranna, David E BloomEngineering (Beijing, China)|May 10, 2021
COVID-19 Vaccine Allocation: Modeling Health Outcomes and Equity Implications of Alternative StrategiesMaddalena Ferranna, Daniel Cadarette, David E BloomPlos Medicine|December 29, 2021
Correction: Social determinants of mortality from COVID-19: A simulation study using NHANESBenjamin Seligman, Maddalena Ferranna, David E BloomPlos One|September 22, 2022
Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoptionNeil G Bennett, David E Bloom, Maddalena FerrannaBMJ Global Health|November 24, 2025
Vaccine selection strategies and their implications for individual versus population well-beingNeil G Bennett, Maddalena Ferranna, Xiaofan Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|June 17, 2024
The economic case for scaling up health research and development: Lessons from the COVID-19 pandemicDaniel Tortorice, Rino Rappuoli, David E BloomHealth Affairs (Project Hope)|February 4, 2021
How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health CrisisDavid E Bloom, Daniel Cadarette, Maddalena Ferranna, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|January 17, 2023
The benefits and costs of U.S. employer COVID-19 vaccine mandatesMaddalena Ferranna, Lisa A Robinson, Daniel Cadarette, et al.Pageof 16